Lynn Kirkpatrick
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer
- Redox biology and oxidative stress
- Angiogenesis and VEGF in Cancer
Papers in
-
- Cancer, Hypoxia, and Metabolism 4
-
- PI3K/AKT/mTOR signaling in cancer 4
- Protein Kinase Regulation and GTPase Signaling 3
- Redox biology and oxidative stress 1
- Co-authors
- Garth Powis (13 shared papers)Ryan R. Williams (7 shared papers)Gillian D. Paine-Murrieta (3 shared papers)Sarah Joanne Welsh (2 shared papers)Nathan T. Ihle (5 shared papers)Robert J. Halter (3 shared papers)Peter Wipf (3 shared papers)Amanda F. Baker (4 shared papers)
- Journals
- Molecular Cancer Therapeutics (4 papers)Cancer Chemotherapy and Pharmacology (2 papers)Experimental Cell Research (1 paper)Biomedicine & Pharmacotherapy (1 paper)Regulatory Toxicology and Pharmacology (1 paper)
- Partner nations
- United StatesBelgiumSouth Korea
In The Last Decade
Lynn Kirkpatrick
16 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 70
- Cancer Research 379
- Molecular Biology 403
- Radiology, Nuclear Medicine and Imaging 72
- Oncology 74
- Genetics 17
Countries citing papers authored by Lynn Kirkpatrick
This map shows the geographic impact of Lynn Kirkpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Kirkpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Kirkpatrick more than expected).
Fields of papers citing papers by Lynn Kirkpatrick
This network shows the impact of papers produced by Lynn Kirkpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Kirkpatrick. The network helps show where Lynn Kirkpatrick may publish in the future.
Co-authors
The 25 scholars most cited alongside Lynn Kirkpatrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 287 | |
| 2 | 2004 | 274 | |
| 3 | Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha. | 2004 | 256 |
| 4 | 2004 | 211 | |
| 5 | 2005 | 113 | |
| 6 | 2010 | 110 | |
| 7 | 2004 | 74 | |
| 8 | 2010 | 72 | |
| 9 | 2004 | 45 | |
| 10 | 2011 | 36 | |
| 11 | 2023 | 29 | |
| 12 | 2009 | 28 | |
| 13 | 2019 | 26 | |
| 14 | 2006 | 25 | |
| 15 | 2015 | 7 | |
| 16 | 2021 | 7 | |
| 17 | 2019 | 0 |
About Lynn Kirkpatrick
Lynn Kirkpatrick is a scholar working on Cancer Research, Molecular Biology, Management of Technology and Innovation, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 17 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Redox biology and oxidative stress (1 paper), Entrepreneurship Studies and Influences (1 paper), MRI in cancer diagnosis (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Cancer Research (379 citations), Molecular Biology (403 citations), Radiology, Nuclear Medicine and Imaging (72 citations), Oncology (74 citations) and Genetics (17 citations). Lynn Kirkpatrick has collaborated with scholars based in United States, Belgium and South Korea. Frequent co-authors include Garth Powis, Ryan R. Williams, Gillian D. Paine-Murrieta, Sarah Joanne Welsh, Nathan T. Ihle, Robert J. Halter, Peter Wipf, Amanda F. Baker, Robert T. Abraham and Margareta I. Berggren. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Chemotherapy and Pharmacology, Experimental Cell Research, Biomedicine & Pharmacotherapy and Regulatory Toxicology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.